Medicine and Dentistry
Glioblastoma
100%
Neoplasm
69%
Ganglioglioma
39%
Pharmacogenomics
26%
Malignant Neoplasm
24%
Cancer
24%
Tumor Progression
21%
Therapeutic Procedure
17%
Brain Tumor
17%
Cytotoxic T-Cell
16%
Clear Cell Renal Cell Carcinoma
16%
Progression Free Survival
15%
Temozolomide
15%
Nodular Melanoma
14%
Recurrent Disease
14%
Tumor Cell
14%
Cancer Cell
13%
Treatment Response
13%
Metastatic Carcinoma
12%
Glioma Stem Cell
12%
Tumor Microenvironment
12%
Molecular Profiling
12%
Pazopanib
12%
Soft Tissue Sarcoma
12%
Phosphotransferase
12%
Targeted Therapy
12%
Durvalumab
10%
Arm
10%
Radiation Therapy
10%
Carcinogenesis
10%
Non Small Cell Lung Cancer
9%
Tumor Recurrence
9%
Drug Response
9%
Phase II Trials
9%
Oncology
9%
Ring Finger
8%
Immunotherapy
8%
Biological Marker
8%
Therapeutic Agent
8%
Lung Cancer
8%
Stomach Tumor
8%
Cell Transdifferentiation
8%
Neuropilin 1
8%
Oncogene
8%
Semaphorin 3A
8%
Metastatic Colorectal Cancer
8%
Sterol Regulatory Element Binding Protein 1c
8%
Kidney Cancer
8%
Female Genital Tract Cancer
8%
Pharmacogenetic Testing
8%
Biochemistry, Genetics and Molecular Biology
Stem Cell
31%
Wild Type
25%
RNA Interference
17%
Isocitrate Dehydrogenase
17%
Cancer Cell
16%
Exome Sequencing
15%
Mouse
14%
Tumor Progression
14%
Radiosensitivity
13%
RNA Sequence
13%
Tumor-Associated Macrophage
12%
T Cell
12%
Drive
12%
Pharmacogenomics
12%
Messenger RNA
12%
Exon
12%
Gene Mutation
11%
Dynamics
10%
Drug Screening
10%
down Regulation
9%
Tumor Suppressor Protein
9%
Microsatellite DNA
9%
Overall Survival
9%
Oncogene
9%
Carcinogenesis
9%
Tumor Suppressor Gene
8%
Genetics
8%
Radiosensitivity
8%
Bevacizumab
8%
G Protein Coupled Receptor
8%
Isoform
8%
IDH1
8%
Genetic Trait
8%
DNA Template
8%
Myeloid
8%
Leucine-Rich Repeat
8%
Missense Mutation
8%
Kirsten Murine Sarcoma Virus
8%
Secretion (Process)
8%
Proteogenomics
8%
Signaling Mechanism
8%
Galactosidase
8%
Tissue Factor
8%
USP1
8%
Coculture
8%
Next Generation Sequencing
8%
Smelling
8%
G Protein Coupled Receptor
8%
Drug Response
8%
Synapsin I
8%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
82%
Neoplasm
42%
Tumor Growth
24%
Neoplasm
16%
Bevacizumab
15%
Metastasis
15%
Malignant Neoplasm
15%
Stomach Cancer
12%
Pharmacogenomics
12%
Renal Cell Carcinoma
12%
Biological Marker
11%
Transcriptome
10%
Carcinogenesis
9%
Recurrent Disease
9%
Antiangiogenic Therapy
9%
Progression Free Survival
9%
Phosphotransferase
9%
Programmed Death 1 Ligand 1
8%
Stomach Tumor
8%
Castration Resistant Prostate Cancer
8%
Semaphorin 3A
8%
Macitentan
8%
Hypophysis Tumor
8%
Epidermal Growth Factor Receptor Antibody
8%
Colon Cancer
8%
Lung Cancer
8%
Female Genital Tract Tumor
8%
Female Genital Tract Cancer
8%
Intrinsic Resistance
8%
Soft Tissue Sarcoma
8%
Pazopanib
8%
Sterol Regulatory Element Binding Protein 1c
8%
Kidney Cancer
8%
Thromboplastin
8%
Melanoma
7%
Isocitrate Dehydrogenase 1
6%
Transcriptome
6%
Epidermal Growth Factor Receptor
6%
Metastatic Colorectal Cancer
5%
Cell Marker
5%
Pancreas Adenocarcinoma
5%
Chemotherapy
5%
